Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-511X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study ; volume:16 ; number:1 ; day:24 ; month:7 ; year:2017 ; pages:1-11 ; date:12.2017
Lipids in health and disease ; 16, Heft 1 (24.7.2017), 1-11, 12.2017

Creator
Choi, Joshua
Contributor
Khan, Amir M.
Jarmin, Michael
Goldenberg, Naila
Glueck, Charles J.
Wang, Ping
SpringerLink (Online service)

DOI
10.1186/s12944-017-0493-7
URN
urn:nbn:de:1111-201708311429
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Choi, Joshua
  • Khan, Amir M.
  • Jarmin, Michael
  • Goldenberg, Naila
  • Glueck, Charles J.
  • Wang, Ping
  • SpringerLink (Online service)

Other Objects (12)